What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cytokine
His scientific interests lie mostly in Cell biology, Antigen, Immunology, Immune system and Innate immune system.
His Signal transduction study in the realm of Cell biology connects with subjects such as Population.
His research in Signal transduction intersects with topics in Acquired immune system and Myeloid.
The Antigen study combines topics in areas such as Cytotoxic T cell, Cancer research and T cell.
His Immunology research is multidisciplinary, incorporating perspectives in Transforming growth factor beta and In vitro.
His study in Immune system is interdisciplinary in nature, drawing from both Confocal microscopy, Cell, Tetraspanin and Green fluorescent protein.
His most cited work include:
- Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. (561 citations)
- Identification of a dendritic cell receptor that couples sensing of necrosis to immunity (522 citations)
- Myeloid C-type lectins in innate immunity (431 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cell biology, Immunology, Immune system, Antigen and Receptor.
His Cell biology study combines topics in areas such as Chemokine, T cell, Cytotoxic T cell and Innate immune system.
As part of his studies on Immunology, he often connects relevant areas like Interleukin 12.
His work carried out in the field of Antigen brings together such families of science as Cancer research, Immunotherapy, Cancer immunotherapy and Monoclonal antibody.
His Receptor research includes themes of Myeloid, Inflammation, Programmed cell death and Bone marrow.
His work in CD8 addresses issues such as Dendritic cell, which are connected to fields such as Syk.
He most often published in these fields:
- Cell biology (60.63%)
- Immunology (34.65%)
- Immune system (29.92%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (60.63%)
- Immune system (29.92%)
- Immunity (13.39%)
In recent papers he was focusing on the following fields of study:
David Sancho focuses on Cell biology, Immune system, Immunity, Dendritic cell and Immunology.
His Cell biology research incorporates elements of Inflammation, Receptor, Chemokine and Chemokine receptor.
His Immune system research is multidisciplinary, relying on both Cytokine, Antibody and Systemic inflammation.
His Immunity research is multidisciplinary, incorporating elements of Acquired immune system, Innate immune system and Nasal administration.
Antigen, Myeloid and Proinflammatory cytokine are the primary areas of interest in his Immunology study.
His work deals with themes such as Cancer research and Cancer immunotherapy, which intersect with Antigen.
Between 2017 and 2021, his most popular works were:
- Dendritic cells in cancer immunology and immunotherapy. (256 citations)
- A Neutrophil Timer Coordinates Immune Defense and Vascular Protection (87 citations)
- Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis (83 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cytokine
David Sancho mainly focuses on Cell biology, Immune system, Immunity, Dendritic cell and T cell.
The various areas that David Sancho examines in his Cell biology study include Chemokine, Receptor and CXCL2.
His Immune system research entails a greater understanding of Immunology.
His work carried out in the field of Immunity brings together such families of science as Inflammation and Innate immune system.
His biological study spans a wide range of topics, including Acquired immune system, Cytotoxic T cell, Sialoadhesin and Sialic acid binding.
His study explores the link between Immunotherapy and topics such as Myeloid that cross with problems in Cancer immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
